Publications
668
Citations
30,918
Est. group size
~23
Recurring co-author estimate
Active years
46
Publishing since 1981
Typically publishes in teams of ~8 · 22% small-team papers (≤3 authors) · across 66 venues
- Abstract PR026: A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1
Cancer Research · 2026
- Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies
Pituitary · 2025
- Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review
Diabetes · 2025
- Osilodrostat Treatment for Adrenal and Ectopic Cushing Syndrome: Integration of Clinical Studies With Case Presentations
Journal of the Endocrine Society · 2025
- Future Directions in the Management of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
The Journal of Clinical Endocrinology & Metabolism · 2025
- A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1
Nature Communications · 2025
- Relacorilant Improved Blood Pressure and Maintained Other Cardiometabolic Improvements in Long-term Study in Patients With Endogenous Hypercortisolism (Cushing Syndrome)
Metabolism · 2025
- SUN-438 Rapid And Sustained Reduction Of 11-oxygenated Androgens In Adults With Classic Congenital Adrenal Hyperplasia Following Once-daily Oral Atumelnant (CRN04894): Results From A 12-week, Phase 2, Open-label Study
Journal of the Endocrine Society · 2025
- SAT-452 Reductions in Adrenal Volume in Patients With Congenital Adrenal Hyperplasia Receiving Once-Daily Oral Atumelnant (CRN04894): Interim Results From a 12-Week, Phase 2, Open-Label Study
Journal of the Endocrine Society · 2025
- Relacorilant improved blood pressure and maintained other cardiometabolic improvements in long-term study in patients with endogenous hypercortisolism (Cushing syndrome)
Endocrine Abstracts · 2025
- Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies
Pituitary · 2025
- Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment
2025
- MON-481 Glucocorticoid (GC) Dosing Across Adults and Children with Congenital Adrenal Hyperplasia (CAH)
Journal of the Endocrine Society · 2025
- Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
2025
- Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes
2025
- Journal of the Endocrine Society×79
- The Journal of Clinical Endocrinology & Metabolism×34
- Endocrine Abstracts×25
- The Journal of Steroid Biochemistry and Molecular Biology×13
- Endocrine Practice×11
- Desmaré van Rooyen
Medicine · University of Michigan
- Chaelin Lee
Medicine · University of Michigan
- Adina F. Turcu
Medicine · University of Michigan
- Peeradon Vibhatavata
Medicine · University of Michigan
- Kazutaka Nanba
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile